ClinicalTrials.govpublic full text
Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors
advanced malignant solid neoplasm, recurrent brain neoplasm, recurrent malignant solid neoplasm, refractory brain neoplasm, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 864617
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.